US investors now have a regulated route to Injective with yield attached: Canary's staked INJ ETF went live on Nasdaq under the ticker INJC.

The fund holds INJ through BitGo Bank & Trust and stakes part of it on the Injective network. The sponsor charges a 1.10% annual fee, while staking fees take up to 30% of rewards, leaving the trust with 70%.

The prospectus puts the implied INJ staking rate at about 6.8% a year as of September 15, 2026.

Staked tokens carry a 21-day unbonding period with no rewards or transfers, so redemption liquidity depends on the unstaked buffer the sponsor keeps. Slashing forfeiture is currently set to zero, but Injective governance can raise it at any time.